Day 2 of iMig 2014 is on October 22, and is not your father’s mesothelioma science conference. In the past, there was little positive to say about medicine and mesothelioma. Today, however, positives are appearing, more and more often, albeit with a long way to go.
Day 2 continues the focus on molecular topics. Michele Carbone and Bruce Robinson each present twice, with Dr. Robinson focused on immunotherapy for mesothelioma, and Dr. Carbone focused on molecular genetics and the BAP1 mutation. Also, there are multiple presentations related to microRNA and mesothelioma, and multiple presentations regarding various, operating biobanks for mesotheliomas. Also notable are the following two presentations:
21.2 S Maki-Nevala 1045
Exome Sequencing Reveals Novel Recurrent Mutations in Asbestos-Exposed Lung Adenocarcinoma and Malignant Mesothelioma
23.8 S Burgers 1215
Occasional Exposure to Asbestos: What is the Risk?
Comments